Uipath, INC Form 4 insider transactions
NYSE
PATH
Uipath, INCUiPath's COO and CFO, Ashim Gupta, reported the sale of Class A Common Stock and shares withheld for tax obligations, reducing his direct beneficial ownership.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $15.9937 per share under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $15.7318 under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $16.38 per share under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 90,000 Class A Common Stock shares in late December 2025 through a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 135,000 shares of Class A Common Stock across three transactions in late December 2025, pursuant to a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines executed planned sales of 90,000 Class A Common Stock shares totaling approximately $1.48 million under a 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines filed an amended Form 4 to correct an inadvertent omission of 9.6 million Class A Common Stock shares held indirectly.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines filed an amended Form 4 to correct an inadvertent omission of 9.6 million indirectly held shares.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $16.07 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 Class A Common Stock shares for $730,156 under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines converted over 9.6 million Class B shares to Class A and subsequently sold 45,000 Class A shares under a pre-arranged plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $731,515 on December 16, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold a total of 90,000 Class A Common Stock shares in December 2025 under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $18.5612 on December 11, 2025, under a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines executed a pre-planned sale of 45,000 Class A Common Stock shares at an average price of $18.6107 on December 10, 2025.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines has filed a Form 4 indicating a planned sale of 45,000 Class A Common Stock shares on December 9, 2025, under a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $19.21 per share under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's General Counsel and Chief Legal Officer, Brad Brubaker, sold 27,580 shares of Class A Common Stock for approximately $18.55 per share under a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath's CEO and Chairman, Daniel Dines, reported the sale of 45,000 Class A Common Stock shares on December 5, 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines reported the sale of 45,000 Class A Common Stock shares at an average price of $15.0748 under a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $15.0243 per share under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines filed a Form 4 disclosing a planned sale of 45,000 Class A Common Stock shares on November 3, 2025, under a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $15.72 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported the sale of 45,000 Class A Common Stock shares for approximately $15.73 per share under a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines reported the sale of 135,000 Class A Common Stock shares over three days in late October 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines executed a pre-planned sale of 45,000 Class A Common Stock shares at an average price of $15.4578 on October 24, 2025, as disclosed in a Form 4 filing.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $683,338 under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $15.5312 per share under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, sold 5,000 shares of Class A Common Stock on October 22, 2025, through a pre-arranged 10b5-1 plan.